We are live on
!
Find out more
MC
Middleton & Co Portfolio holdings
AUM
$877M
1-Year Est. Return
15.2%
This Fund
S&P 500
This Quarter
Est. Return
+6.44%
1 Year Est. Return
+15.2%
3 Year Est. Return
+63.4%
5 Year Est. Return
+82.2%
10 Year Est. Return
+352.6%
AUM
$456M
AUM Growth
+$13M
(+2.9%)
Cap. Flow
-$15.4M
Cap. Flow
% of AUM
-3.38%
Top 10 Holdings %
Top 10 Hldgs %
27.45%
Holding
159
New
4
Increased
30
Reduced
95
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CDK
CDK Global, Inc.
CDK
|
+$3.28M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$3.11M |
| 3 |
American Tower
AMT
|
+$1.76M |
| 4 |
JPMorgan Chase
JPM
|
+$1.63M |
| 5 |
Starbucks
SBUX
|
+$1.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Small-Cap ETF
IJR
|
+$2.47M |
| 2 |
Biogen
BIIB
|
+$1.77M |
| 3 |
CVS Health
CVS
|
+$1.71M |
| 4 |
FL
Foot Locker
FL
|
+$1.66M |
| 5 |
Cognizant
CTSH
|
+$1.56M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.12% |
| 2 | Financials | 15.58% |
| 3 | Technology | 14.21% |
| 4 | Consumer Discretionary | 12.24% |
| 5 | Communication Services | 10.63% |
Similar funds
AGDI
SFA
HT
OHA
ACA
AE
SA
F1I
Middleton & Co's Q1 2017 Portfolio in Review
As of Q1 2017, Middleton & Co held 159 positions worth $456M, up 2.9% from $443M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Middleton & Co withdrew a net $15.4M in Q1 2017, closing 6 positions and reducing 95 holdings. Its most notable exit was Biogen, an estimated $1.77M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 19% a quarter earlier, followed by Financials and Technology.
Against the trend, Middleton & Co opened a new position in J.M. Smucker worth $553K.
- Middleton & Co's largest Q1 2017 buy was J.M. Smucker: 4,220 shares worth $553K.
- Middleton & Co added most to CDK Global, Inc. in Q1 2017, an estimated $3.28M increase.
- Middleton & Co's biggest Q1 2017 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $2.47M.
- Middleton & Co fully exited Biogen in Q1 2017, selling an estimated $1.77M.
- Middleton & Co's ten largest holdings make up 27% of its $456M portfolio in Q1 2017.
- Middleton & Co opened 4 new positions and closed 6 in Q1 2017.
- Middleton & Co's portfolio value rose 2.9% quarter-over-quarter to $456M.
Based on Middleton & Co's 13F filing for Q1 2017, filed 19 Apr 2017.